HomeTOP STORIES23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256... 23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million By rogerjudd May 19, 2025 FacebookTwitterPinterestWhatsApp Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services. Previous articleWhat to Know About the Mexican Navy Ship That Crashed Into the Brooklyn BridgeNext articleTAT Technologies GAAP EPS of $0.34 beats by $0.04, revenue of $42.14M misses by $0.45M latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds